Billing Details
Report Name

U.S. Biosimilar Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Filgrastim & Pegfilgrastim, Monoclonal Antibodies and Others), By Disease Indication (Caner, Auto Immune Diseases (Arthritis, Psoriasis, Neutropenia, and others), and Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast, 2020-2027

Shopping Cart
Report Id License Type Price
FBI100990 $ 2850
Total $ 2850
Continue for Payment Method

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.